Cargando…

Contingency Management for Patients Receiving Medication for Opioid Use Disorder: A Systematic Review and Meta-analysis

IMPORTANCE: Medication treatment for opioid use disorder (MOUD) is efficacious, but comorbid stimulant use and other behavioral health problems often undermine efficacy. OBJECTIVE: To examine the association of contingency management, a behavioral intervention wherein patients receive material incen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bolívar, Hypatia A., Klemperer, Elias M., Coleman, Sulamunn R. M., DeSarno, Michael, Skelly, Joan M., Higgins, Stephen T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2021
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340014/ https://www.ncbi.nlm.nih.gov/pubmed/34347030 http://dx.doi.org/10.1001/jamapsychiatry.2021.1969

Ejemplares similares

Looking to the empirical literature on the potential for financial incentives to enhance adherence with COVID-19 vaccination
por: Higgins, Stephen T., et al.
Publicado: (2021)

Effect of Smartphone-Based Financial Incentives on Peripartum Smoking Among Pregnant Individuals: A Randomized Clinical Trial
por: Kurti, Allison N., et al.
Publicado: (2022)

Patient-Reported Goals of Youths in Canada Receiving Medication-Assisted Treatment for Opioid Use Disorder
por: Chai, Darren, et al.
Publicado: (2021)

Association of Opioid Dose Reduction With Opioid Overdose and Opioid Use Disorder Among Patients Receiving High-Dose, Long-term Opioid Therapy in North Carolina
por: DiPrete, Bethany L., et al.
Publicado: (2022)

Contingency Management: Incentives for Sobriety
por: Higgins, Stephen T., et al.
Publicado: (1999)

Rewarding recovery: the time is now for contingency management for opioid use disorder
por: Proctor, Steven L.
Publicado: (2022)

Analysis of Stimulant Prescriptions and Drug-Related Poisoning Risk Among Persons Receiving Buprenorphine Treatment for Opioid Use Disorder
por: Mintz, Carrie M., et al.
Publicado: (2022)

Use of Medication for Opioid Use Disorder Among US Adolescents and Adults With Need for Opioid Treatment, 2019
por: Mauro, Pia M., et al.
Publicado: (2022)

Association of US Medical Marijuana Laws With Nonmedical Prescription Opioid Use and Prescription Opioid Use Disorder
por: Segura, Luis E., et al.
Publicado: (2019)

Necessity and Contingency in Developmental Genetic Screens: EGF, Wnt, and Semaphorin Pathways in Vulval Induction of the Nematode Oscheius tipulae
por: Vargas-Velazquez, Amhed M., et al.
Publicado: (2019)

Bupropion Slow Release vs Placebo With Adaptive Incentives for Cocaine Use Disorder in Persons Receiving Methadone for Opioid Use Disorder: A Randomized Clinical Trial
por: Ware, Orrin D., et al.
Publicado: (2023)

Contingent Convergence: The Ability To Detect Convergent Genomic Evolution Is Dependent on Population Size and Migration
por: Whiting, James R., et al.
Publicado: (2019)

Opioid Dose Trajectories and Associations With Mortality, Opioid Use Disorder, Continued Opioid Therapy, and Health Plan Disenrollment
por: Binswanger, Ingrid A., et al.
Publicado: (2022)

Comparative Effectiveness of Opioid Tapering or Abrupt Discontinuation vs No Dosage Change for Opioid Overdose or Suicide for Patients Receiving Stable Long-term Opioid Therapy
por: Larochelle, Marc R., et al.
Publicado: (2022)

Prescribing of Opioid Analgesics and Buprenorphine for Opioid Use Disorder During the COVID-19 Pandemic
por: Currie, Janet M., et al.
Publicado: (2021)

Access to Primary Care Clinics for Patients With Chronic Pain Receiving Opioids
por: Lagisetty, Pooja A., et al.
Publicado: (2019)

Assessment of 2-Year Neurodevelopmental Outcomes in Extremely Preterm Infants Receiving Opioids and Benzodiazepines
por: Puia-Dumitrescu, Mihai, et al.
Publicado: (2021)

5-HT modulation by acute tryptophan depletion of human instrumental contingency judgements
por: Chase, Henry W., et al.
Publicado: (2010)

High opioid doses, naloxone, and central nervous system active medications received by Medicare‐enrolled adults
por: Silva Almodóvar, Armando, et al.
Publicado: (2022)

Characteristics of US Counties With High Opioid Overdose Mortality and Low Capacity to Deliver Medications for Opioid Use Disorder
por: Haffajee, Rebecca L., et al.
Publicado: (2019)

Contingent negative variation as a dopaminergic biomarker: evidence from dose-related effects of methylphenidate
por: Linssen, Anke M. W., et al.
Publicado: (2011)

Evaluation of Buprenorphine Rotation in Patients Receiving Long-term Opioids for Chronic Pain: A Systematic Review
por: Powell, Victoria D., et al.
Publicado: (2021)

Assessment of Community-Level Vulnerability and Access to Medications for Opioid Use Disorder
por: Joudrey, Paul J., et al.
Publicado: (2022)

Cognitive Outcomes of Young Children After Prenatal Exposure to Medications for Opioid Use Disorder: A Systematic Review and Meta-analysis
por: Nelson, Leah F., et al.
Publicado: (2020)

Association of Pregnancy and Insurance Status With Treatment Access for Opioid Use Disorder
por: Patrick, Stephen W., et al.
Publicado: (2020)

State- and County-Level Geographic Variation in Opioid Use Disorder, Medication Treatment, and Opioid-Related Overdose Among Medicaid Enrollees
por: Lindner, Stephan R., et al.
Publicado: (2023)

Changes in Prescribed Opioid Dosages Among Patients Receiving Medical Cannabis for Chronic Pain, New York State, 2017-2019
por: Nguyen, Trang, et al.
Publicado: (2023)

Implementation support for contingency management: preferences of opioid treatment program leaders and staff
por: Scott, Kelli, et al.
Publicado: (2021)

Association of State Policies Allowing Medical Cannabis for Opioid Use Disorder With Dispensary Marketing for This Indication
por: Shover, Chelsea L., et al.
Publicado: (2020)

Trends in Use of Medication to Treat Opioid Use Disorder During the COVID-19 Pandemic in 10 State Medicaid Programs
por: Austin, Anna E., et al.
Publicado: (2023)

Integrating Opioid Use Disorder Treatment Into Primary Care Settings
por: Austin, Elizabeth J., et al.
Publicado: (2023)

Economic Evaluation of Extended-Release Buprenorphine for Persons With Opioid Use Disorder
por: Flam-Ross, Juliet M., et al.
Publicado: (2023)

Estimated Costs and Outcomes Associated With Use and Nonuse of Medications for Opioid Use Disorder During Incarceration and at Release in Massachusetts
por: Chatterjee, Avik, et al.
Publicado: (2023)

Association of Opioid Use Disorder Treatment With Alcohol-Related Acute Events
por: Xu, Kevin Y., et al.
Publicado: (2021)

Assessment of Racial and Ethnic Disparities in the Use of Medication to Treat Opioid Use Disorder Among Pregnant Women in Massachusetts
por: Schiff, Davida M., et al.
Publicado: (2020)

Changes in Cigarette Consumption With Reduced Nicotine Content Cigarettes Among Smokers With Psychiatric Conditions or Socioeconomic Disadvantage: 3 Randomized Clinical Trials
por: Higgins, Stephen T., et al.
Publicado: (2020)

Mobile Telemedicine for Buprenorphine Treatment in Rural Populations With Opioid Use Disorder
por: Weintraub, Eric, et al.
Publicado: (2021)

The impact of the implementation of medication for opioid use disorder and COVID-19 in a statewide correctional system on treatment engagement, postrelease continuation of care, and overdose
por: Klemperer, Elias M., et al.
Publicado: (2023)

Association Between Opioid Dose Variability and Opioid Overdose Among Adults Prescribed Long-term Opioid Therapy
por: Glanz, Jason M., et al.
Publicado: (2019)

Comparison of Rates of Overdose and Hospitalization After Initiation of Medication for Opioid Use Disorder in the Inpatient vs Outpatient Setting
por: Morgan, Jake R., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ckaniui5h4toeeef7ia00ioj0l